Hanmi Pharmaceutical Expands Middle East Presence with Neutropenia Drug 'Rolontis'

Hanmi Pharmaceutical has signed a supply agreement with Saudi Arabia's Tabuk Pharmaceuticals to launch its FDA-approved neutropenia biologic 'Rolontis' in the Middle East, marking a major step in the company's global expansion strategy.